In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam

Autor:	J. Guzmán-Puche, E. Pérez-Nadales, M. Pérez-Vázquez, M. Causse, I. Gracia-Ahufinger, A. Mendez-Natera, Y. Allalou-Ruiz, C. Elías, J. Oteo-Iglesias, J. Torre-Cisneros, L. Martínez-Martínez
Rok vydání:	2021
Předmět:	Microbiology (medical) General Medicine Microbial Sensitivity Tests Ceftazidime beta-Lactamases Anti-Bacterial Agents Klebsiella Infections Drug Combinations Klebsiella pneumoniae Infectious Diseases Bacterial Proteins Drug Resistance Bacterial Humans Pharmacology (medical) Azabicyclo Compounds
Zdroj:	International journal of antimicrobial agents. 59(2)
ISSN:	1872-7913
Popis:	Ceftazidime/avibactam (CZA) is used to treat infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp). Resistance to CZA is commonly related to point mutations in the bla
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::920a182e80104d81c338fcb9f8cc1305 https://pubmed.ncbi.nlm.nih.gov/35038557 Zobrazit plný text záznamu Full Text from ScienceDirect